Clinical trial–derived risk model may not generalize to real-world patients with acute coronary syndrome

This publication has 29 references indexed in Scilit:

• Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events
  Archives of internal medicine (1960), 2003
• An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
  European Heart Journal, 2002
• Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial InfarctionResults From a Randomized Trial
  JAMA, 2001
• Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project
  Journal of the American College of Cardiology, 2001
• Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
  New England Journal of Medicine, 2001
• Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy
  Journal of the American College of Cardiology, 2000
• The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
  JAMA, 2000
• Prediction of 1-Year Survival After Thrombolysis for Acute Myocardial Infarction in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries Trial
  Circulation, 2000
• PREDICT: A Simple Risk Score for Clinical Severity and Long-Term Prognosis After Hospitalization for Acute Myocardial Infarction or Unstable Angina
  Circulation, 1999
• Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels
  New England Journal of Medicine, 1999